Need help? Text us and our team of experts will reply in minutes +00 00 00000

Hexarelin

CAS #: 140703-51-1

Hexarelin

Research Use Only

All products are intended solely for laboratory research and are not for human or animal consumption. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.

Hexarelin Overview

Hexarelin functions as a multi-pathway peptide agonist influencing endocrine signaling, downstream cascades, and vascular responses through multiple target receptor pathways. As a synthetic hexapeptide secretagogue-type compound that acts as a potent agonist with enhanced stability and potency compared to natural ligands, Hexarelin demonstrates broad signaling activity. Research models examine Hexarelin’s effects on pulsatile dynamics, downstream pathway stimulation, vascular signaling, and endocrine modulation in laboratory and preclinical experimental settings, with particular interest in its vascular and systemic actions.

Xu et al. (2014).

History

Hexarelin was developed in the 1990s as part of systematic research into secretagogue-type peptides, following the identification of GHRP-6 and other early compounds in this class. Synthesized to optimize signaling potency and duration of action, Hexarelin emerged as one of the most potent synthetic secretagogue compounds. Subsequent research revealed its unexpected vascular signaling effects independent of the somatotroph axis, leading to expanded investigation of its vascular pathway applications.

Granata et al. (2014).

Hexarelin Structure

CAS#: 140703-51-1

Molecular Formula: C₄₇H₅₈N₁₂O₆

Molecular Weight: 887.04 g/mol

PubChem ID: 6918245

Research Findings

Hexarelin has been investigated in secretagogue research and vascular pharmacology studies, with particular focus on target pathway activation, vascular signaling mechanisms, endocrine effects, and multi-system signaling responses in experimental models and assay-based systems.

Key Areas of Research:

  • Endocrine: Somatotroph axis, signaling, cascades

  • Vascular: Signaling, remodeling, pathway dynamics

  • Systemic: Lipid pathways, substrate dynamics, markers

  • Pharmacology: Target binding, dual pathway, distribution

Together, these findings demonstrate Hexarelin’s versatility as a research compound across endocrine, vascular, and systemic pathways. Through dual pathway engagement, Hexarelin provides a unique experimental platform for studying somatotroph axis modulation, vascular signaling mechanisms, and integrated endocrine-vascular dynamics in diverse research settings.

Huang et al., International Heart Journal, 2017

Our Process

STEP 1

Precision Lyophilization

Manufactured in a controlled U.S. facility under strict compounding standards.

STEP 2

Verified Purity

Every batch third-party tested with HPLC and mass spectrometry.

STEP 3

Same-Day Fulfillment

Orders dispatched same-day from our U.S. facility.
Text us, our dedicated team is here to help
Orders dispatched same-day from our U.S. facility.
Frequently Asked Questions

Orders dispatched same-day from our U.S. facility.

Each vial contains exactly what’s shown on the label. For example, a 10mg vial has exactly 10mg of lyophilized peptide. Researchers can divide it into smaller portions—like four 2.5mg measurements—but the total amount remains 10mg.

Peptides are supplied as lyophilized powder. They do not come reconstituted, and any extra supplies must be sourced separately for research applications.
In lyophilized powder form, peptides stay stable for up to 2 years. After reconstitution, it should be refrigerated and is generally stable for up to 2 months.

Products from Raw Peptides do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.

Lyophilized peptides should be stored away from heat and light. Once reconstituted, they must be refrigerated to maintain stability and efficacy.